Celebrating 50 years of scientific
advancement –
 learn more
JCR pharmaceuticals logo. Click here to go to the home page
  • Visit JCR Japan
  • Visit JCR Japan
  • Home
  • Who we are
  • Innovation
  • Pipeline
  • Patients & families
  • Our commitment
  • Partnerships
  • Investors & media
  • Our products
  • Contact us

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Reports

FY2025 second quarter results briefing session material


by Moises Zanetti

FY2025 second quarter results briefing session - movie


by Moises Zanetti

FY2025 Second quarter results briefing session material


by Moises Zanetti

FY2025-Q2 Financial report (Jul. 1-Sep. 30, 2025)


by Moises Zanetti

Corporate governance report


by Moises Zanetti

FY2025 first quarter results conference call script


by Moises Zanetti

Corporate governance report


by Moises Zanetti

Consolidated financial results for the three months ended June 30, 2025 (FY2025)


by Moises Zanetti

FY2025 first quarter results conference call


by Moises Zanetti

Notice regarding the completion of payment for the disposition of treasury stock as restricted stock compensation


by Moises Zanetti

  • 1
  • 2
  • 3
Contact us
JCR pharmaceuticals logo. Click here to go to the home page

  • Sitemap
  • Compliance
  • Privacy policy
  • Global policy
  • Cookie policy
  • Cookie settings

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Privacy Preference Center

Privacy Preferences